secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2024-12-05T23:59:59+00:00
Accession:  0001213900-24-106095
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD annual meeting votes: all director nominees elected, say-on-pay approved, auditor ratified
--------------------------------------------------------------------------------

- All four board nominees elected: Thompson 4.60M for, Collins 4.73M, Naughton 4.64M, Roberts 4.63M; broker non-votes 1.97M each.
- Non-binding advisory vote on 2023 exec comp: 4.61M for, 218K against, 30K abstain; broker non-votes 1.97M.
- Ratification of Berkowitz Pollack Brant as auditor for FY2024: 6.44M for, 383K against, 12K abstain; no broker non-votes.
- Meeting held Dec 5, 2024; quorum of 6.83M shares (59.2% of 11.53M outstanding shares).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000121390024106095/0001213900-24-106095-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000121390024106095/ea0223856-8k_therap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-106095

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer